Immucor (BLUD) to be acquired by TPG Capital for $27/share in cash ($1.97B). Immucor makes...

|By:, SA News Editor

Immucor (BLUD) to be acquired by TPG Capital for $27/share in cash ($1.97B). Immucor makes equipment used by blood banks, hospitals, and labs to test blood prior to transfusions. (PR) Good call by Andrew August back in March.